Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway

By Yanping Zhang, G. Wolf, K. Bhat, Aiwen Jin, T. Allio, W. Burkhart, Y. Xiong. Molecular and Cellular Biology, 2003

600 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/0b0312fdb90bf5d82732eec77bf7b3b1175df29b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. W. Gu
2. C. Brooks
3. Hua Lu
4. Xiaoping Zhou

In Oncology

1. W. Gu
2. C. Brooks

Citations in the corpus

• p53 ubiquitination: Mdm2 and beyond. (2006, background): “Ribosome proteins such as L11 and L23 can all inhibit the activity of Mdm2 on p53 (Dai et al., 2004; Lohrum et al., 2003; Zhang et al., 2003).”
• Ribosomal proteins: functions beyond the ribosome. (2015, background): “Over the past decade, more than a dozen of RPs, including RPL5 (Dai and Lu, 2004), RPL6 (Bai et al., 2014), RPL11 (Lohrum et al., 2003; Zhang et al., 2003), RPL23 (Dai et al., 2004; Jin et al., 2004), RPL26 (Zhang et al., 2010), RPL37 (Daftuar et al., 2013), RPS3 (Yadavilli et al., 2009), RPS7…”